for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Dedalus France SA

DEDAL.PA

Latest Trade

--

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

--

 - 

--

As of on the Euronext Paris ∙ Minimum 15 minute delay

Pricing

Previous Close
--
Open
--
Volume
--
3M AVG Volume
0.25
Today's High
--
Today's Low
--
52 Week High
--
52 Week Low
--
Shares Out (MIL)
112.34
Market Cap (MIL)
42.33
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

Dedalus H1 Net Loss Widens To EUR 2 Mln

Dedalus France Announces Creation Of Robotics Division

Medasys Raises 9.4 Million Euros In Capital Increase

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Dedalus France SA

Dedalus France SA, formerly known as Medasys SA, is a France-based company that is primarily engaged in the design, production and publication of software used in the medical and scientific sectors. The Company produces a range of software solutions for healthcare establishments, such as for organizing patient files, nursing treatment, identity servers and organizing appointments. It also provides software solutions for areas such as laboratories oncology, biology, imaging, radiology departments and pharmacies. Dedalus France SA operates through a number of its wholly-owned subsidiaries, including Medasys Digital Systems Sprl, Medasys Digital Systems Inc., Medasys Ltd., Mega-Bus SAS and Mexys SAS. The Company operates through MedHealth Moroc and Netika.

Industry

Software & Programming

Contact Info

22, avenue Galilee

+33.1.75609100

https://www.dedalus-france.fr/

Executive Leadership

Florence Hofmann

Independent Chairman of the Supervisory Board

Frederic Vaillant

Chairman of the Management Board

Andrea Corbani

Vice Chairman of the Supervisory Board

Jean-Paul Boulier

Member of the Management Board

Simona Campo di Costa Vigolo e Fredana

Member of the Management Board

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Price To Earnings (TTM)
14.46
Price To Sales (TTM)
1.02
Price To Book (MRQ)
1.11
Price To Cash Flow (TTM)
5.87
Total Debt To Equity (MRQ)
33.95
LT Debt To Equity (MRQ)
20.40
Return on Investment (TTM)
4.18
Return on Equity (TTM)
2.68

Latest News

Latest News

UPDATE 1-Italy's Dedalus in exclusive talks to buy part of Agfa-Gevaert IT business

Clinical healthcare software group Dedalus is in exclusive talks to buy part of Belgium-based Agfa-Gevaert's healthcare information technology business for an enterprise value of 975 million euros ($1.07 billion), the companies said on Monday.

Italy's Dedalus in exclusive talks with Agfa-Gevaert to buy its IT business

Italian clinical healthcare software group Dedalus said on Monday it has submitted an offer and entered into exclusive negotiations to buy part of Agfa-Gevaert's healthcare information technology business.

Compugroup shortlisted in Agfa Gevaert unit sale: sources

Belgian digital imaging company Agfa Gevaert <AGFB.BR> has shortlisted Germany's Compugroup Medical <COPMa.DE> and Ardian-backed Italian firm Dedalus in the auction for its healthcare information technology business, people close the matter said.

Agfa Gevaert expects multiple bids for healthcare IT unit: sources

Belgian digital imaging company Agfa Gevaert <AGFB.BR> expects offers from rivals and private equity firms as it opens an auction of its healthcare information technology business on Tuesday, people close to the matter said.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up